1 / 16

Good Morning!

Good Morning!. Friday, August 3 rd 2012. Semantic Qualifiers. Illness Script. Predisposing Conditions Age, gender, preceding events (trauma, viral illness, etc), medication use, past medical history (diagnoses, surgeries, etc) Pathophysiological Insult

devi
Download Presentation

Good Morning!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Good Morning! Friday, August 3rd 2012

  2. Semantic Qualifiers

  3. Illness Script • Predisposing Conditions • Age, gender, preceding events (trauma, viral illness, etc), medication use, past medical history (diagnoses, surgeries, etc) • Pathophysiological Insult • What is physically happening in the body, organisms involved, etc. • Clinical Manifestations • Signs and symptoms • Labs and imaging

  4. Predisposing Conditions: Pertussis • Highest incidence • Infants <6mos (not completely immunized) • Adolescents (due to waning immunity) • Important infectious source for infants/children • Risk factors • Childcare, school outbreaks • Sick caregiver

  5. Pathophysiology: Pertussis • Organism: Bordetellapertussis • Gram-negative pleomorphic bacillus • Bordetellaparapertussis– milder disease • Transmitted via coughing (aerosolized droplets) • Infect ciliated epithelium of respiratory tract • Toxins cause local and systemic effects • Plugs of necrotic bronchial epithelial tissues and thick mucus in airways • VERY contagious during earliest (catarrhal) stage

  6. Clinical Manifestations: Pertussis • Classic pertussis syndrome (ages 1-10yrs)** • 3 stages • Catarrhal – nonspecific signs; lasts 1-2 weeks • Nasal congestion, rhinorrhea, sneezing, tearing, low-grade fever • Paroxysmal – most distinctive stage; lasts 2-4 weeks • Paroxysms of coughing during expiration • Forceful inhalation “whoop” • http://www.pkids.org/diseases/pertussis.html • Post-tussive emesis • Convalescent – resolution of symptoms; lasts 1-2 weeks • Coughing becomes less severe; whoops disappear • Residual cough may last for months

  7. Clinical Manifestations: Pertussis • Infants: not classic** • Apnea (can hypoxia leading to CNS damage) • No classic “whoop” • Secondary bacterial pneumonia common • Adolescents/adults: not classic** • Prolonged bronchitis-like illness • Persistent, nonproductive cough • Begins as nonspecific URI • Generally do not have “whoop”, but will have paroxysms of cough • Cough lasts weeks-months

  8. Diagnosis** • Definitive diagnosis based on culture of B. pertussisfrom nasopharyngeal specimen • VERY difficult to isolate • DFA of nasopharyngeal secretions • Technically difficult; low sensitivity (~60%) • PCR is the preferred method • More sensitive and specific • CBC: marked leukocytosis and lymphocytosis

  9. Treatment** • Age < 6 months: strongly consider admit • Close monitoring (cyanosis, apnea), frequent suctioning, O2, IVFs, nutrition • Antibiotics • 1st line: macrolide • 2nd line: TMP-SMX • Early treatment (catarrhal stage) eradicates nasopharygeal carriage, shortens duration of illness • However, treatment during the paroxysmal stage does NOT alter the clinical course • Does reduce the spread of secondary cases • Can return to school after treatment x 5 days

  10. Treatment

  11. Prophylaxis** • ALL close contacts should receive prophylaxis (including child care/school contacts) • Antibiotics • Same agents, dose, duration as for treatment of pertussis • Best if within 21 days of onset of cough in index case • Immunization • Close contacts who are unimmunized or underimmunized should also have pertussis vaccine initiated or continued immediately • DTaP: for children <7 years old • Tdap: for children ages >7 years old

  12. Routine Pertussis Vaccine Recommendations • DTaP: 5 doses • 2months, 4months, 6months, 15-18months, 4-6years • Tdap: 1 dose • 11-12years • Immunization with Tdap (if not received previously) is recommended for adults who will have close contact with an infant aged <12 months (at least 2 weeks prior to contact with the infant) • Contraindications for pertussis vaccine**: • Allergic reaction, unstable or active CNS disease, encephalopathy within 7 days of receiving prior pertussis vaccine

  13. Waning Immunization** • Neither infection with active disease or vaccination provides complete or lifelong immunity • Protection begins to wane 3-5 years after vaccination • No discernable immunity after 12 years

  14. THANK YOU!! Noon conference: Residents as Teachers (Dr. English) Students off!!

More Related